Search results
Results from the WOW.Com Content Network
Latent TB is treated with either isoniazid or rifampin alone, or a combination of isoniazid with either rifampicin or rifapentine. [140] [141] [142] The treatment takes three to nine months depending on the medications used. [75] [140] [143] [142] People with latent infections are treated to prevent them from progressing to active TB disease ...
Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB.. The medical standard for active TB is a short course treatment involving a combination of isoniazid, rifampicin (also known as Rifampin), pyrazinamide, and ethambutol for the first two months.
MDR-TB most commonly develops in the course of TB treatment, [5] and is most commonly due to doctors giving inappropriate treatment, or patients missing doses or failing to complete their treatment. Because MDR tuberculosis is an airborne pathogen, persons with active, pulmonary tuberculosis caused by a multidrug-resistant strain can transmit ...
A 2008 study in the Tomsk oblast of Russia, reported that 14 out of 29 (48.3%) patients with XDR-TB successfully completed treatment. [16] In 2018, the WHO reported that the treatment success rate for XDR-TB was 34% for the 2015 cohort, compared to 55% for MDR/RR-TB (2015 cohort), 77% for HIV-associated TB (2016 cohort), and 82% for TB (2016 ...
Common radiological findings after TB include lesions to the airway, such as obstructive lung disease and bronchiectasis, lesions to the parenchyma, such as calcification, fibrosis, and Aspergillosis, chronic pleural disease, pulmonary hypertension, and other findings. [5]
Mycobacterium tuberculosis (M. tb), also known as Koch's bacillus, is a species of pathogenic bacteria in the family Mycobacteriaceae and the causative agent of tuberculosis. [ 1 ] [ 2 ] First discovered in 1882 by Robert Koch , M. tuberculosis has an unusual, waxy coating on its cell surface primarily due to the presence of mycolic acid .
Steroids can be used in the first six weeks of treatment, [20] A few people may require immunomodulatory agents such as thalidomide. [21] Hydrocephalus occurs as a complication in about a third of people with TB meningitis. The addition of aspirin may reduce or delay mortality, possibly by reducing complications such as cerebral infarctions ...
Constrictive pericarditis is the main long-term complication of tuberculous pericarditis that requires management. [5] Corticosteroids have long been thought to help reduce the risk of future cardiac complications. [3] [7] Colchicine is a drug thought to reduce the recurrence of constrictive pericarditis, although evidence is limited. [5]